EP3177307
Hvítfrumuboða-2/hvítfrumuboða-2 viðtaka alfa samrunaprótín og aðferðir til notkunar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.8.2015EP published:
17.7.2024EP application number:
15750560.3
EP translation filed:
12.8.2024Grant published:
15.9.2024EPO information:
European Patent Register
Max expiry date:
4.8.2035Expiry date:
4.8.2026Next due date:
31.8.2026
Title in English:
INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USELanguage of the patent:
English
Timeline
Today
5.8.2015EP application
17.7.2024EP Publication
12.8.2024Translation submitted
15.9.2024Registration published
4.8.2026Expires
Owner
Name:
The University of MiamiAddress:
1951 NW 7th Avenue Suite 110, Miami, Florida 33136, US
Inventor
Name:
MALEK, ThomasAddress:
Miami Beach, Florida 33139, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462033726 PDate:
6.8.2014Country:
US
Classification
Categories:
A61K 38/00, C07K 14/55
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 19.8.2024
Expires: 4.8.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 18.7.2025
Expires: 4.8.2026
Payer: Árnason Faktor ehf.